RxDoctor Payments Data

Dana Chandler, DO

Family Medicine · Mt Pleasant, TNNPI 1518143122

Payments from drug & device makers

$11,680in general payments, 2019–2025

Across 712 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • Amgen$922
  • Pfizer$868
  • Lilly USA, LLC$782
  • AstraZeneca$679
  • plus $5K from 39 others

What the payments were for

  • Food & beverage$11,56299%
  • Education$1181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,680 in reported general payments places this provider in the 90th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$75,061
Medicare patients
184
Services billed
1,364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide93$116,351
JardianceEmpagliflozin70$104,887
FarxigaDapagliflozin Propanediol52$65,067
EliquisApixaban32$49,461
Repatha SureclickEvolocumab60$44,772
MounjaroTirzepatide26$36,633
XareltoRivaroxaban40$35,811
JanuviaSitagliptin Phosphate22$34,127
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$25,798
TrulicityDulaglutide11$22,228
Tresiba Flextouch U-100Insulin Degludec26$16,455
Ezetimibe265$6,877
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$5,686
PaxlovidNirmatrelvir/Ritonavir13$5,396
Atorvastatin Calcium364$4,847

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$1,888$117,429106 claims
Boehringer IngelheimJardiance$403$104,88770 claims
AstraZenecaFarxiga$679$65,06752 claims
Lilly USA, LLCMounjaro, Trulicity$782$58,86237 claims
PfizerEliquis, Paxlovid$868$54,85645 claims
Johnson & JohnsonXarelto$520$35,81140 claims
MerckJanuvia$214$34,12722 claims
GSKTrelegy Ellipta$461$25,79817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Mt Pleasant

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →